magrolimab – Talk Bio

Actionable Insights Powered by AI

Gilead’s Magrolimab Ineffective, Linked to Increased Risk of Death in MDS Patients

10 months ago talkbio0Tagged Clinical Trials, concerns, Gilead, magrolimab, Malignant Neoplasms, Miller Dieker syndrome, MYELODYSPLASTIC SYNDROME, Safety

Gilead, Magrolimab, MDS, Myelodysplastic Syndrome, Cancer Treatment, Clinical Trials, Safety Concerns

Gilead’s Magrolimab Linked to Increased Risk of Death in Blood Cancer Patients

10 months ago talkbio0Tagged Clinical Research, Enhance (action), Gilead, Hematologic Neoplasms, Increased, magrolimab, Risk of Death

Gilead, Magrolimab, Blood Cancer, Increased Risk of Death, ENHANCE Study